Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris

Condition:   Moderate to Severe Acne Vulgaris Interventions:   Drug: BOS-356;   Drug: Vehicle Sponsor:   Boston Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acne | Research | Study